intention Search Results


predictive intents  (Bob Evans Farms Inc)
90
Bob Evans Farms Inc predictive intents
Predictive Intents, supplied by Bob Evans Farms Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/us11580112-557-33-34?v=Bob+Evans+Farms+Inc
Average 90 stars, based on 1 article reviews
predictive intents - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
vaccination intention  (Schmid GmbH)
90
Schmid GmbH vaccination intention
Vaccination Intention, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pmc10757889-66-43-45?v=Schmid+GmbH
Average 90 stars, based on 1 article reviews
vaccination intention - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
ressources à l'intention des intervenants auprès des aînés  (Merck KGaA)
90
Merck KGaA ressources à l'intention des intervenants auprès des aînés
Ressources à L'intention Des Intervenants Auprès Des Aînés, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/10__1007_slash_bf03403997-134-16-14?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
ressources à l'intention des intervenants auprès des aînés - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
voter intention data  (YouGov plc)
90
YouGov plc voter intention data
Voter Intention Data, supplied by YouGov plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pm35400183-235-0-0?v=YouGov+plc
Average 90 stars, based on 1 article reviews
voter intention data - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
implementation intention  (Stamm GmbH)
90
Stamm GmbH implementation intention
Implementation Intention, supplied by Stamm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pm36504401-78-11-20?v=Stamm+GmbH
Average 90 stars, based on 1 article reviews
implementation intention - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
astrazeneca vaccination intention  (AstraZeneca ltd)
90
AstraZeneca ltd astrazeneca vaccination intention
Astrazeneca Vaccination Intention, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pmc09915047-12-1-0?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
astrazeneca vaccination intention - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
intent-to-treat (itt) analysis  (KGK Science Inc)
90
KGK Science Inc intent-to-treat (itt) analysis
Body weight and body fat percentage of overweight adults who consumed supplement shake preloads with high protein and high fiber (HPF) or low protein and lower fiber (LPF) for 12 wk. <t>Intent-to-treat</t> analyses on the change from baseline (day 0) in body weight (A) and body fat % (C) and per-protocol analyses on the change from baseline (day 0) in body weight (B) and body fat % (D). For the intent-to-treat analysis, between-group differences were assessed using ANCOVA, with time as a within-participants fixed effect, group as a between-participants fixed effect, and their interaction [body-weight sample sizes: day 28, n = 89 (LPF) and n = 98 (HPF); day 56, n = 79 (LPF) and n = 89 (HPF); and day 84 n = 73 (LPF) and n = 80 (HPF); body-fat sample sizes, n = 71 (LPF) and n = 79 (HPF)]. For the per-protocol analysis, noncompliant participants were removed and data modeled using generalized least-squares regression with the same main and interaction effects, but with both baseline and sex as covariates [ n = 68 (LPF) and n = 65 (HPF) for all time points]. Values are presented as estimated marginal means ± SEs. *Different from LPF at that time, P < 0.05 (Tukey-adjusted between-group comparison). # Different from day 0, P < 0.05 (Tukey-adjusted within-participant comparison). † Different from day 0, P < 0.05 (Wilcoxon signed-rank test). ‡ Different from LPF at that time, P < 0.05 (Wilcoxon signed-rank test).
Intent To Treat (Itt) Analysis, supplied by KGK Science Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pmc09178960-200-1-8?v=KGK+Science+Inc
Average 90 stars, based on 1 article reviews
intent-to-treat (itt) analysis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
velico® prototype commercial intent disposables  (Velico Medical Inc)
90
Velico Medical Inc velico® prototype commercial intent disposables
Body weight and body fat percentage of overweight adults who consumed supplement shake preloads with high protein and high fiber (HPF) or low protein and lower fiber (LPF) for 12 wk. <t>Intent-to-treat</t> analyses on the change from baseline (day 0) in body weight (A) and body fat % (C) and per-protocol analyses on the change from baseline (day 0) in body weight (B) and body fat % (D). For the intent-to-treat analysis, between-group differences were assessed using ANCOVA, with time as a within-participants fixed effect, group as a between-participants fixed effect, and their interaction [body-weight sample sizes: day 28, n = 89 (LPF) and n = 98 (HPF); day 56, n = 79 (LPF) and n = 89 (HPF); and day 84 n = 73 (LPF) and n = 80 (HPF); body-fat sample sizes, n = 71 (LPF) and n = 79 (HPF)]. For the per-protocol analysis, noncompliant participants were removed and data modeled using generalized least-squares regression with the same main and interaction effects, but with both baseline and sex as covariates [ n = 68 (LPF) and n = 65 (HPF) for all time points]. Values are presented as estimated marginal means ± SEs. *Different from LPF at that time, P < 0.05 (Tukey-adjusted between-group comparison). # Different from day 0, P < 0.05 (Tukey-adjusted within-participant comparison). † Different from day 0, P < 0.05 (Wilcoxon signed-rank test). ‡ Different from LPF at that time, P < 0.05 (Wilcoxon signed-rank test).
Velico® Prototype Commercial Intent Disposables, supplied by Velico Medical Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/us12337260-3416-1-0?v=Velico+Medical+Inc
Average 90 stars, based on 1 article reviews
velico® prototype commercial intent disposables - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
intention-to-treat analysis  (METTLER TOLEDO)
90
METTLER TOLEDO intention-to-treat analysis
Body weight and body fat percentage of overweight adults who consumed supplement shake preloads with high protein and high fiber (HPF) or low protein and lower fiber (LPF) for 12 wk. <t>Intent-to-treat</t> analyses on the change from baseline (day 0) in body weight (A) and body fat % (C) and per-protocol analyses on the change from baseline (day 0) in body weight (B) and body fat % (D). For the intent-to-treat analysis, between-group differences were assessed using ANCOVA, with time as a within-participants fixed effect, group as a between-participants fixed effect, and their interaction [body-weight sample sizes: day 28, n = 89 (LPF) and n = 98 (HPF); day 56, n = 79 (LPF) and n = 89 (HPF); and day 84 n = 73 (LPF) and n = 80 (HPF); body-fat sample sizes, n = 71 (LPF) and n = 79 (HPF)]. For the per-protocol analysis, noncompliant participants were removed and data modeled using generalized least-squares regression with the same main and interaction effects, but with both baseline and sex as covariates [ n = 68 (LPF) and n = 65 (HPF) for all time points]. Values are presented as estimated marginal means ± SEs. *Different from LPF at that time, P < 0.05 (Tukey-adjusted between-group comparison). # Different from day 0, P < 0.05 (Tukey-adjusted within-participant comparison). † Different from day 0, P < 0.05 (Wilcoxon signed-rank test). ‡ Different from LPF at that time, P < 0.05 (Wilcoxon signed-rank test).
Intention To Treat Analysis, supplied by METTLER TOLEDO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pmc11227320-943-4-31?v=METTLER+TOLEDO
Average 90 stars, based on 1 article reviews
intention-to-treat analysis - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
demographic voter intention data  (YouGov plc)
90
YouGov plc demographic voter intention data
Body weight and body fat percentage of overweight adults who consumed supplement shake preloads with high protein and high fiber (HPF) or low protein and lower fiber (LPF) for 12 wk. <t>Intent-to-treat</t> analyses on the change from baseline (day 0) in body weight (A) and body fat % (C) and per-protocol analyses on the change from baseline (day 0) in body weight (B) and body fat % (D). For the intent-to-treat analysis, between-group differences were assessed using ANCOVA, with time as a within-participants fixed effect, group as a between-participants fixed effect, and their interaction [body-weight sample sizes: day 28, n = 89 (LPF) and n = 98 (HPF); day 56, n = 79 (LPF) and n = 89 (HPF); and day 84 n = 73 (LPF) and n = 80 (HPF); body-fat sample sizes, n = 71 (LPF) and n = 79 (HPF)]. For the per-protocol analysis, noncompliant participants were removed and data modeled using generalized least-squares regression with the same main and interaction effects, but with both baseline and sex as covariates [ n = 68 (LPF) and n = 65 (HPF) for all time points]. Values are presented as estimated marginal means ± SEs. *Different from LPF at that time, P < 0.05 (Tukey-adjusted between-group comparison). # Different from day 0, P < 0.05 (Tukey-adjusted within-participant comparison). † Different from day 0, P < 0.05 (Wilcoxon signed-rank test). ‡ Different from LPF at that time, P < 0.05 (Wilcoxon signed-rank test).
Demographic Voter Intention Data, supplied by YouGov plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pm35400183-175-5-9?v=YouGov+plc
Average 90 stars, based on 1 article reviews
demographic voter intention data - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
intentional artificial intelligence coding’ feature  (ATLAS.ti)
90
ATLAS.ti intentional artificial intelligence coding’ feature
Execution of Braun and Clarke's six phases of thematic analysis in the analysis of the co-production workshops <xref ref-type= 29 " width="250" height="auto" />
Intentional Artificial Intelligence Coding’ Feature, supplied by ATLAS.ti, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pmc11733491-87-9-8?v=ATLAS.ti
Average 90 stars, based on 1 article reviews
intentional artificial intelligence coding’ feature - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
preregistered, prospective intention to screen trial protocol  (EMMES Corporation)
90
EMMES Corporation preregistered, prospective intention to screen trial protocol
Execution of Braun and Clarke's six phases of thematic analysis in the analysis of the co-production workshops <xref ref-type= 29 " width="250" height="auto" />
Preregistered, Prospective Intention To Screen Trial Protocol, supplied by EMMES Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/intention/pmc07055592-20-60-56?v=EMMES+Corporation
Average 90 stars, based on 1 article reviews
preregistered, prospective intention to screen trial protocol - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Body weight and body fat percentage of overweight adults who consumed supplement shake preloads with high protein and high fiber (HPF) or low protein and lower fiber (LPF) for 12 wk. Intent-to-treat analyses on the change from baseline (day 0) in body weight (A) and body fat % (C) and per-protocol analyses on the change from baseline (day 0) in body weight (B) and body fat % (D). For the intent-to-treat analysis, between-group differences were assessed using ANCOVA, with time as a within-participants fixed effect, group as a between-participants fixed effect, and their interaction [body-weight sample sizes: day 28, n = 89 (LPF) and n = 98 (HPF); day 56, n = 79 (LPF) and n = 89 (HPF); and day 84 n = 73 (LPF) and n = 80 (HPF); body-fat sample sizes, n = 71 (LPF) and n = 79 (HPF)]. For the per-protocol analysis, noncompliant participants were removed and data modeled using generalized least-squares regression with the same main and interaction effects, but with both baseline and sex as covariates [ n = 68 (LPF) and n = 65 (HPF) for all time points]. Values are presented as estimated marginal means ± SEs. *Different from LPF at that time, P < 0.05 (Tukey-adjusted between-group comparison). # Different from day 0, P < 0.05 (Tukey-adjusted within-participant comparison). † Different from day 0, P < 0.05 (Wilcoxon signed-rank test). ‡ Different from LPF at that time, P < 0.05 (Wilcoxon signed-rank test).

Journal: The Journal of Nutrition

Article Title: Consuming a Protein and Fiber-Based Supplement Preload Promotes Weight Loss and Alters Metabolic Markers in Overweight Adults in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

doi: 10.1093/jn/nxac038

Figure Lengend Snippet: Body weight and body fat percentage of overweight adults who consumed supplement shake preloads with high protein and high fiber (HPF) or low protein and lower fiber (LPF) for 12 wk. Intent-to-treat analyses on the change from baseline (day 0) in body weight (A) and body fat % (C) and per-protocol analyses on the change from baseline (day 0) in body weight (B) and body fat % (D). For the intent-to-treat analysis, between-group differences were assessed using ANCOVA, with time as a within-participants fixed effect, group as a between-participants fixed effect, and their interaction [body-weight sample sizes: day 28, n = 89 (LPF) and n = 98 (HPF); day 56, n = 79 (LPF) and n = 89 (HPF); and day 84 n = 73 (LPF) and n = 80 (HPF); body-fat sample sizes, n = 71 (LPF) and n = 79 (HPF)]. For the per-protocol analysis, noncompliant participants were removed and data modeled using generalized least-squares regression with the same main and interaction effects, but with both baseline and sex as covariates [ n = 68 (LPF) and n = 65 (HPF) for all time points]. Values are presented as estimated marginal means ± SEs. *Different from LPF at that time, P < 0.05 (Tukey-adjusted between-group comparison). # Different from day 0, P < 0.05 (Tukey-adjusted within-participant comparison). † Different from day 0, P < 0.05 (Wilcoxon signed-rank test). ‡ Different from LPF at that time, P < 0.05 (Wilcoxon signed-rank test).

Article Snippet: An intent-to-treat (ITT) analysis was independently conducted by KGK Science, Inc., with a follow-up per-protocol (PP) analysis conducted by Traverse Science, Inc., that only included compliant participants with complete data from the primary outcomes.

Techniques: Comparison

Execution of Braun and Clarke's six phases of thematic analysis in the analysis of the co-production workshops <xref ref-type= 29 " width="100%" height="100%">

Journal: BJPsych Open

Article Title: Subcutaneous electroencephalography monitoring for people with epilepsy and intellectual disability: co-production workshops

doi: 10.1192/bjo.2024.825

Figure Lengend Snippet: Execution of Braun and Clarke's six phases of thematic analysis in the analysis of the co-production workshops 29

Article Snippet: Coding of the data was conducted using the ATLAS.ti ‘Intentional artificial intelligence coding’ feature, which codes the transcripts based on user-provided research questions or aims.

Techniques: Generated, Comparison

Research questions specified for the intentional artificial intelligence coding process

Journal: BJPsych Open

Article Title: Subcutaneous electroencephalography monitoring for people with epilepsy and intellectual disability: co-production workshops

doi: 10.1192/bjo.2024.825

Figure Lengend Snippet: Research questions specified for the intentional artificial intelligence coding process

Article Snippet: Coding of the data was conducted using the ATLAS.ti ‘Intentional artificial intelligence coding’ feature, which codes the transcripts based on user-provided research questions or aims.

Techniques: